EU EMA Announces Sanofi Winthrop Industrie Withdrew Its Application For The Use Of Dupixent In The Treatment Of Adults With Moderate-To-Severe Bullous Pemphigoid On June 24

Benzinga Newsdesk www.benzinga.com Neutral 94.2%

Neg 0% Neu 94.2% Pos 0%

https://www.ema.europa.eu/en/medicines/human/variation/dupixent

Comments

No comments yet. Be the first!